290
R. Tan et al. / Journal of Catalysis 255 (2008) 287–295
Scheme 3. Synthesis of the IL-functionalized chiral salen Mn(III) complexes 2, 3, and 4.
for C18H27ClN2O: C, 66.96; H, 8.43; N, 8.68. Found: C, 66.89;
H, 8.52; N, 8.57%. 1H NMR (CDCl3, 400 MHz): δ ppm 13.78
(s, 1 H), 8.29 (s, 1 H), 7.28 (s, 1 H), 7.11 (s, 1 H), 4.58 (s, 2 H),
3.32 (s, 1 H), 2.05–1.44 (m, 10 H), 1.42 (s, 9 H). FT-IR (KBr):
3449, 2956, 2858, 1630, 1582, 1547, 1480, 1468, 1442, 1386,
1351, 1340, 1325, 1291, 1270, 1240, 1224, 1200, 1173, 1153,
tion. After cooling to 5 ◦C overnight, the complex thus obtained
was collected by removal of toluene, washed completely with
hexane for several times, and dried in vacuum to obtain a deep-
yellow solid of IL-CL1 (2.26 g, 91%) or IL-CL2 (3.89 g, 82%).
IL-CL1: Calc. for C40H63BF4N5O2: C, 65.56; H, 8.67; N, 9.56.
1
Found: C, 65.50; H, 8.74; N, 9.73%. H NMR (CDCl3, 400
1081, 1054, 1043, 942, 859, 823, 798, 717, 646 cm−1
.
MHz): δ ppm 14.25 (s, 1 H), 13.68 (s, 1 H), 8.93 (s, 1 H), 8.45
(s, 1 H), 8.29 (s, 1 H), 7.58 (d, 1 H), 7.47 (d, 1 H), 7.30 (d, 1 H),
7.26 (d, 1 H), 6.99 (d, 1 H), 6.89 (d, 1 H), 4.56 (s, 2 H), 4.32 (m,
2 H), 4.17 (t, 2 H), 3.60–3.34 (m, 2 H), 2.70 (m, 2 H), 2.4 (s,
1 H), 1.88–1.49 (m, 8 H), 1.40 (s, 9 H), 1.28 (s, 18 H), 0.88 (t,
3 H). FT-IR (KBr): 3443, 3144, 2956, 2864, 2013, 1630, 1547,
1530, 1468, 1439, 1390, 1363, 1313, 1269, 1252, 1240, 1204,
1173, 1135, 1084, 1037, 982, 939, 879, 828, 772, 731, 712, 642,
621 cm−1. IL-CL2: Calc. for C44H72B2F8N8O2: C, 57.52; H,
7.90; N, 12.20. Found: C, 57.41; H, 7.97; N, 12.32%. 1H NMR
(CDCl3, 400 MHz): δ ppm 13.68 (s, 2 H), 8.91 (s, 2 H), 8.42
(s, 2 H), 7.60 (d, 2 H), 7.49 (d, 2 H), 7.31 (d, 2 H), 7.23 (d,
2 H), 4.58 (s, 4 H), 4.29 (m, 4 H), 4.15 (t, 4 H), 3.55–3.30 (m,
2 H), 2.70 (m, 4 H), 2.4 (s, 2 H), 1.89–1.44 (m, 8 H), 1.32 (s, 18
H), 0.85 (t, 6 H). FT-IR (KBr): 3448, 3146, 3089, 2953, 2861,
2013, 1630, 1547, 1530, 1471, 1438, 1390, 1363, 1339, 1313,
1272, 1246, 1204, 1174, 1089, 1031, 874, 830, 772, 712, 642,
2.3.2. Synthesis of chiral salen ligand 1 (CL1) and chiral
salen ligand 2 (CL2)
In this procedure, 8 mmol of the previously obtained HL1
(for the synthesis of CL1) or HL2 (for the synthesis of CL2)
was dissolved in 20 mL of dry ethanol. The solution was added
dropwise to 20 mL of dry ethanol containing 8 mmol of 3-
tert-butyl-5-(chloro-methyl)-2-hydroxybenzaldehyde at ambi-
ent temperature. The resulting mixture was gradually heated to
60 ◦C and stirred for 8 h. The slurry thus obtained was cooled
in ice-water bath over 3 h. Then the solid obtained was fil-
tered and recrystallized from ethanol to give pale-yellow pow-
der of CL1 (3.55 g, 85%) or CL2 (3.38 g, 82%). CL1: Calc. for
C33H47ClN2O2: C, 73.51; H, 8.79; N, 5.20. Found: C, 73.58;
H, 8.75; N, 5.13%. 1H NMR (CDCl3, 400 MHz): δ ppm 14.29
(s, 1 H), 13.67 (s, 1 H), 8.44 (s, 1 H), 8.31 (s, 1 H), 7.30 (d,
1 H), 7.26 (d, 1 H), 6.99 (d, 1 H), 6.89 (d, 1 H), 4.43 (s, 2 H),
3.55–3.32 (m, 2 H), 1.97–1.46 (m, 8 H), 1.40 (s, 9 H), 1.23 (s,
18 H). FT-IR (KBr): 3446, 2954, 2865, 1630, 1591, 1479, 1468,
1439, 1391, 1362, 1271, 1253, 1241, 1202, 1174, 1135, 1085,
1037, 982, 939, 879, 828, 803, 772, 731, 711, 644 cm−1. CL2:
Calc. for C30H40Cl2N2O2: C, 67.79; H, 7.58; N, 5.27. Found:
621 cm−1
.
2.4. Preparation of IL-functionalized chiral salen Mn(III)
complexes 2, 3, and 4
The preparation of complexes 2, 3, and 4 is outlined in
Scheme 3. Under vigorous stirring, 15 mL of dry ethanol con-
taining 8 mmol of manganese acetate was added dropwise to
15 mL of dry ethanol solution containing 4 mmol of chiral salen
ligand IL-CL1 (for the synthesis of complex 2) or IL-CL2 (for
the synthesis of complex 3) at 50 ◦C under nitrogen protection.
The mixture was refluxed for 5 h, then cooled to ambient tem-
perature. Then 10 mL of ethanol containing 24 mmol of lithium
chloride was added to the mixture under stirring for 3 h. Af-
ter bubbling with a gentle stream of air for another 2 h, the
mixture was exposed to air overnight. The resulting slurry was
cooled to 5 ◦C for 2 h, filtered, and washed with 50 mL of wa-
ter. The solid thus obtained was dried under vacuum at 40 ◦C to
1
C, 67.71; H, 7.69; N, 5.32%. H NMR (CDCl3, 400 MHz):
δ ppm 13.68 (s, 2 H), 8.42 (s, 2 H), 7.31 (d, 2 H), 7.26 (d, 2 H),
4.58 (s, 4 H), 3.55–3.30 (m, 2 H), 1.89–1.44 (m, 8 H), 1.42 (s,
18 H). FT-IR (KBr): 3449, 2952, 2866, 1630, 1594, 1545, 1466,
1439, 1390, 1361, 1308, 1266, 1229, 1200, 1167, 1142, 1091,
1030, 974, 930, 871, 778, 753, 669 cm−1
.
2.3.3. Synthesis of IL-CL1 and IL-CL2
First, 15 mL of dry toluene containing 5 mmol of the CL1
(for the synthesis of IL-CL1) or the chiral salen ligand CL2
(for the synthesis of IL-CL2) was added to equiv. of IL. The
resulting mixture was refluxed for 48 h under nitrogen protec-